Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations.
Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations.
复制标题
DOI：
10.3748/wjg.v24.i1.124
复制
发表时间：
2018-01-07
影响因子：
4.3
通讯作者：
von Renteln D
中科院分区：
文献类型：
--
作者：
Bénard F;Barkun AN;Martel M;von Renteln D
总结和比较全球结直肠癌（CRC）筛查建议，以确定相似性和差异。使用MEDLINE、EMBASE、Scopus、CENTRAL和ISI Web of knowledge进行系统性文献检索，识别过去10年内所有平均风险CRC筛查指南出版物和/或过去2年内发表的立场声明。此外，还手动检索了美国国家胃肠病学会网站、国家指南交换中心、BMJ临床证据网站、Google和Google Scholar的网页。确定了15项准则。北美发表了6份指南，欧洲4份，亚洲4份，世界胃肠病组织1份。大多数指南建议使用结肠镜检查（每10年一次）或乙状结肠镜检查（FS，每5年一次）或粪便隐血试验（FOBT，主要是粪便免疫化学试验，每年或每两年一次）筛查年龄在50至75岁之间的平均风险个体。在不同的指南中发现了与结肠镜检查的使用、测试之间的等级顺序、筛查间隔和筛查的最佳年龄范围有关的差异。50至75岁的平均风险人群应接受CRC筛查。关于最佳监测间隔、首选检查/检查级联以及开始和停止筛选的最佳时间的建议因地区而异，应在临床决策时予以考虑。此外，当地资源的可用性和患者的偏好对于增加CRC筛查的吸收非常重要，因为任何筛查都比没有好。
To summarize and compare worldwide colorectal cancer (CRC) screening recommendations in order to identify similarities and disparities. A systematic literature search was performed using MEDLINE, EMBASE, Scopus, CENTRAL and ISI Web of knowledge identifying all average-risk CRC screening guideline publications within the last ten years and/or position statements published in the last 2 years. In addition, a hand-search of the webpages of National Gastroenterology Society websites, the National Guideline Clearinghouse, the BMJ Clinical Evidence website, Google and Google Scholar was performed. Fifteen guidelines were identified. Six guidelines were published in North America, four in Europe, four in Asia and one from the World Gastroenterology Organization. The majority of guidelines recommend screening average-risk individuals between ages 50 and 75 using colonoscopy (every 10 years), or flexible sigmoidoscopy (FS, every 5 years) or fecal occult blood test (FOBT, mainly the Fecal Immunochemical Test, annually or biennially). Disparities throughout the different guidelines are found relating to the use of colonoscopy, rank order between test, screening intervals and optimal age ranges for screening. Average risk individuals between 50 and 75 years should undergo CRC screening. Recommendations for optimal surveillance intervals, preferred tests/test cascade as well as the optimal timing when to start and stop screening differ regionally and should be considered for clinical decision making. Furthermore, local resource availability and patient preferences are important to increase CRC screening uptake, as any screening is better than none.
登录
查看更多内容
影响因子：
9.3
作者：
Kaminski MF;Bretthauer M;Zauber AG;Kuipers EJ;Adami HO;van Ballegooijen M;Regula J;van Leerdam M;Stefansson T;Påhlman L;Dekker E;Hernán MA;Garborg K;Hoff G
通讯作者：
Hoff G
影响因子：
15.8
作者：
Elmunzer BJ;Hayward RA;Schoenfeld PS;Saini SD;Deshpande A;Waljee AK
通讯作者：
Waljee AK
影响因子：
12.6
作者：
Kahi, Charles J.;Imperiale, Thomas F.;Rex, Douglas K.
通讯作者：
Rex, Douglas K.
影响因子：
1.6
作者：
Alsanea, Nasser;Almadi, Majid A.;Morgan, Rebecca L.
通讯作者：
Morgan, Rebecca L.
影响因子：
9.8
作者：
de Wijkerslooth, Thomas R.;de Haan, Margriet C.;Dekker, Evelien
通讯作者：
Dekker, Evelien